Ruan van Heerden
-
Symrise develops a highly effective solution for itchy scalp
Discover SymSoft Scalp by Symrise—a breakthrough ingredient that soothes itchy scalps fast and restores hair comfort. Suitable for shampoos and conditioners, it acts at the source of irritation and repairs hair fibres, making relief from discomfort easier than ever. Find out how SymSoft Scalp can transform your hair care.
-
in-cosmetics Asia postponed to 2021
Due to ongoing travel restrictions and safety concerns, in-cosmetics Asia has been postponed to 2-4 November 2021. Discover how these changes may affect your plans and what to expect from Asia-Pacific’s leading beauty ingredient event.
-
Innovative sugar-based surfactants offer sensory and formulation benefits
Discover GlucoTain, Clariant’s new sugar-based surfactants delivering mild, sulphate-free cleansing with rich foam and skin-friendly benefits. Unlock innovative, sustainable solutions for hair and skin care that don’t compromise on performance—find out how GlucoTain can elevate your next formulation.
-
Skin care ingredients dominate shortlist for in-cosmetics awards 2020
Discover which skin care ingredients are leading innovation at the in-cosmetics Global Awards 2020, with top brands competing for top honours. See which breakthrough actives made the shortlist—and get ready for the winners to be revealed at the inaugural virtual event on 6 October.
-
New web-based training from Alec Cameron
Discover Alec Cameron’s new web-based training platform—offering top-quality, affordable courses trusted by South Africa’s FMCG leaders for over 25 years. Explore how you can access expert-driven skills development, anywhere and anytime.
-
CLR appoints Nathalie Gruber director of Marketing and Corporate Communications
CLR welcomes Nathalie Gruber as the new director of Marketing and Corporate Communications, bringing over a decade of experience to lead global strategies. Discover how her vision is set to drive CLR’s growth and professionalise communications worldwide.
-
Gilead, AstraZeneca and Pfizer likely to win the COVID-19 treatment development race
Gilead, AstraZeneca and Pfizer are leading the race to develop effective COVID-19 treatments, with Gilead’s remdesivir standing out for its proven results. Discover how these pharma giants are shaping the future of pandemic response.
-
Adcock Ingram achieves satisfying financial results despite challenging conditions
Adcock Ingram delivered a strong performance with a 4% rise in turnover, overcoming tough economic headwinds and supply chain challenges. Discover how the Group maintained steady growth, controlled expenses, and upheld vital medicine supplies during a challenging year.
-
Avon calls on Women of South Africa to share Herstory
Avon invites the women of South Africa to share their journeys and celebrate Women’s Month by highlighting stories of hope and triumph. Join us as we amplify women’s voices and inspire others to break barriers—your story could light the way for another.
-
How to prevent skin reactions caused by non-compliant hand sanitiser
Most hand sanitisers sold in South Africa don’t meet legal safety standards, with some containing far less alcohol than claimed. Find out from experts how these non-compliant products could harm your skin—and what you can do to protect yourself.
-
Givaudan acquires French biotechnology company
Givaudan has acquired innovative French biotech company Alderys, strengthening its expertise in bio-engineering and sustainable solutions for the chemical, cosmetic, and nutrition industries. This move expands Givaudan’s portfolio of natural, bio-sourced products—discover how this acquisition supports their long-term growth and commitment to sustainability.
-
Iberchem expands activity in Africa
Iberchem Group strengthens its South African presence by uniting Iberchem, Scentium, and Versachem as Iberchem South Africa, following the full acquisition of Versachem. This move aims to better serve local customers and signals exciting growth ahead for the region. Discover how this expansion could benefit your business.
